Robert Sackstein, M.D.,Ph.D.
This page shows the publications Robert Sackstein has written about Neoplastic Stem Cells.
CD44 and HCELL: preventing hematogenous metastasis at step 1. FEBS Lett. 2011 Oct 20; 585(20):3148-58.
A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity. Blood. 2000 Oct 15; 96(8):2765-74.
Bone vascular niche E-selectin induces mesenchymal-epithelial transition and Wnt activation in cancer cells to promote bone metastasis. Nat Cell Biol. 2019 05; 21(5):627-639.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.